Level Bio AB (NGM:LEVBIO) Cyclically Adjusted Revenue per Share: kr0.55 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LEVBIO Level Bio AB NGM:LEVBIO
23 GF Score
Price kr0.26
! 4 Warning Signs
View Full Analysis

What is Level Bio AB Cyclically Adjusted Revenue per Share?

Level Bio AB NGM:LEVBIO +8.47% 23 Cyclically Adjusted Revenue per Share is kr0.55 as of Mar. 2026. GuruFocus rates NGM:LEVBIO with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Level Bio AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr0.132. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr0.55 for the trailing ten years ended in Mar. 2026.

During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Level Bio AB was 15.20% per year. The lowest was 0.00% per year. And the median was 9.25% per year.

As of today (2026-08-05), Level Bio AB's current stock price is kr0.256. Level Bio AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr0.55. Level Bio AB's Cyclically Adjusted PS Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Level Bio AB was 0.81. The lowest was 0.36. And the median was 0.58.


Level Bio AB  (NGM:LEVBIO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Level Bio AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.256/0.55
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Level Bio AB was 0.81. The lowest was 0.36. And the median was 0.58.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Level Bio AB Cyclically Adjusted Revenue per Share Related Terms


Level Bio AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Level Bio AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Cyclically Adjusted Revenue per Share Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.55 0.57 0.56 0.55

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.55 0.55 0.55 0.55

NGM:LEVBIO vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Level Bio AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Cyclically Adjusted PS Ratio falls into.


NGM:LEVBIO
23GF Score
Level Bio AB NGM:LEVBIO
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Level Bio AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.132/133.5600*133.5600
=0.132

Current CPI (Mar. 2026) = 133.5600.

Level Bio AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.104 101.019 0.138
201609 0.136 101.138 0.180
201612 0.172 102.022 0.225
201703 0.135 102.022 0.177
201706 0.000 102.752 0.000
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.071 103.962 0.091
201806 0.000 104.875 0.000
201809 0.088 105.679 0.111
201812 0.105 105.912 0.132
201903 0.068 105.886 0.086
201906 0.098 106.742 0.123
201909 0.066 107.214 0.082
201912 0.089 107.766 0.110
202003 0.120 106.563 0.150
202006 0.117 107.498 0.145
202009 0.093 107.635 0.115
202012 0.115 108.296 0.142
202103 0.184 108.360 0.227
202106 0.251 108.928 0.308
202109 0.110 110.338 0.133
202112 0.180 112.486 0.214
202203 0.209 114.825 0.243
202206 0.095 118.384 0.107
202209 0.092 122.296 0.100
202212 0.153 126.365 0.162
202303 0.133 127.042 0.140
202306 0.088 129.407 0.091
202309 0.112 130.224 0.115
202312 0.096 131.912 0.097
202403 0.090 132.205 0.091
202406 0.090 132.716 0.091
202409 0.072 132.304 0.073
202412 0.109 132.987 0.109
202503 0.093 132.825 0.094
202506 0.116 133.699 0.116
202509 0.099 133.480 0.099
202512 0.172 133.390 0.172
202603 0.132 133.560 0.132

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr0.55 mean?
Level Bio AB (NGM:LEVBIO) has a Cyclically Adjusted Revenue per Share of kr0.55 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Level Bio AB and its competitors.
Is Level Bio AB's Cyclically Adjusted Revenue per Share too high?
Level Bio AB's current Cyclically Adjusted Revenue per Share is kr0.55. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Level Bio AB's Cyclically Adjusted Revenue per Share of kr0.55 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Level Bio AB and its competitors. Level Bio AB's current Cyclically Adjusted Revenue per Share is kr0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (NGM:LEVBIO) has a current Cyclically Adjusted Revenue per Share of kr0.55. The current Cyclically Adjusted Revenue per Share is kr0.55. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Level Bio AB (NGM:LEVBIO), the current Cyclically Adjusted Revenue per Share is kr0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for NGM:LEVBIO

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.26
Price